| Net loss | -6.19M |
| Depreciation and amortization | 12.78M |
| Inventory valuation allowance | |
| Deferred income taxes | -11K |
| Non-cash interest expense | |
| Loss (gain) on disposal of property and equipment | |
| Loss on ARS settlement right | |
| Gain on ARS | |
| Stock-based compensation expense | 2.87M |
| Other | |
| Accounts receivable | 4.36M |
| Other receivables | 7.66M |
| Inventories | |
| Inventory deposit | |
| Other current assets | |
| Accounts payable | -11.27M |
| Accrued wages and bonuses | -2.31M |
| Accrued restructuring | -380K |
| Deferred income | |
| Other accrued liabilities | -293K |
| Net cash provided by operating activities | 2.64M |
| Acquisition of Pactolus, net of cash acquired | |
| Proceeds from sale of auction rate securities | |
| Capital expenditures | -3.42M |
| Restricted cash | |
| Purchase of long-term assets | |
| Proceeds from the sale of property and equipment | |
| Net cash provided by (used in) investing activities | -3.42M |
| Restricted share forfeitures for tax settlement | |
| Borrowings on line of credit | |
| Payments on line of credit | -64.5M |
| Payments on capital lease obligation | |
| Repurchases of common stock | |
| Proceeds from issuance of common stock | |
| Net cash used in financing activities | 7.28M |
| Effect of exchange rate changes on cash | 216K |
| Net increase in cash and cash equivalents | 6.72M |
| Cash and Cash Equivalents, beginning of period | 20.76M |
| Cash and Cash Equivalents, end of period | 27.48M |
| Interest | 410K |
| Income Taxes paid | 864K |
| Capital lease obligation | |